Expression of epidermal growth factor receptor on oral squamous cell carcinoma

https://doi.org/10.1016/0266-4356(88)90090-3Get rights and content

Abstract

The expression of the receptor for epidermal growth factor (EGF) in normal oral mucosa, papillomas and squamous cell carcinoma (SCC) has been determined by immunohistology and autophophorylation studies. Immunoreactive receptor was localised using two antibodies which recognise the receptor; EGFR1 which reacts with sequences in the external domain of the receptor and F4 which recognises sequences in the internal domain. EGFR was present on basal, suprabasal and some spinous cells of normal oral mucosa. Regional variation in the distribution of receptor was apparent. A similar pattern of receptor expression was seen on oral papillomas. The distribution and intensity of epidermal growth factor receptor (EGFR) expression varied between 20 patients with oral SCC. The staining patterns seen with the two antibodies were similar on all tissue types. The protein tyrosine-kinase activity of the receptor present on eight oral SCC was also examined by immunoprecipitation and autophosphorylation studies. This procedure also demonstrated variations in the amount of functional EGFR in these tumours. There was no significant correlation between the level of EGFR expression and tumour behaviour.

References (30)

  • G. Carpenter et al.

    Epidermal growth factor

    Annual Review of Biochemistry

    (1979)
  • G. Carpenter

    Epidermal growth factor: biology and receptor metabolism

    Journal of Cell Science

    (1985)
  • L.B. Chen et al.

    Control of a cell surface major glycoprotein by epidermal growth factor

    Science

    (1977)
  • J. Downward et al.

    Close similarity of epidermal growth factor receptor and v-erb B oncogene protein sequences

    Nature

    (1984)
  • J.E. De Larco et al.

    Growth factors from murine sarcoma virus-transformed cells

  • Cited by (81)

    • Targeted inactivation of EPS8 using dendrimer-mediated delivery of RNA interference

      2019, International Journal of Pharmaceutics
      Citation Excerpt :

      Coupled with rapid uptake into cells, this suggests that ligand-conjugated dendrimers likely represent a highly efficient means to deliver therapeutic agents to target cells. Many squamous cell carcinomas express high levels of the EGFR compared to normal keratinocytes (Cardinali et al., 1995; Ozanne et al., 1986; Partridge et al., 1988; Prime et al., 1994), making it an attractive gateway into the cancer cell. However, a major concern with the use of EGF as a targeting ligand is the potential for stimulation of growth-promoting pathways, which would be undesirable in cancer treatment.

    • Loss of CD151/Tspan24 from the complex with integrin α3β1 in invasive front of the tumour is a negative predictor of disease-free survival in oral squamous cell carcinoma

      2013, Oral Oncology
      Citation Excerpt :

      Its value, however, as a predictive and prognostic indicator is undermined by the lack of consistency between studies. Indeed, association between EGFR expression, disease stage at presentation, patient survival and response to EGFR-targeted therapies show significant discrepancies between cohorts.2,20,22–26 These analyses were carried out using the quantitative-evaluation of EGFR levels in the malignant lesions treated as uniform entities.

    • Established and Emerging Concepts in Epidermal Growth Factor Receptor Biology

      2007, International Journal of Radiation Oncology Biology Physics
    • Epidermal growth factor receptor distribution in pericoronal follicles: relationship with the origin of odontogenic cysts and tumors

      2007, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology
      Citation Excerpt :

      Cells presenting a membrane-only staining pattern seem to respond more quickly to changes in the levels of circulating ligand, whereas cells presenting cytoplasm-only or combined staining, in which all or some of the receptor has been internalized, show a slower, more physiologic response.33 Our findings concerning EGFR distribution in NOM are similar to previous descriptions: presence of EGFR in the epithelial cells of proliferating layers,15,34,35,37,38 decreasing in intensity toward superficial layers.38 The cells in the parabasal and basal layers are in constant proliferation for the maintenance of tissue homeostasis.

    View all citing articles on Scopus
    View full text